DoW Neurofibromatosis Research Academy - Scholar Award
This grant supports early-career researchers within 10 years of their terminal degree to conduct innovative neurofibromatosis research as part of the Neurofibromatosis Research Academy, with required mentorship.
Funder: Defense Health Agency Contracting Activity - DHACA
Due Dates: September 8, 2026: Pre-Application (Letter of Intent) | September 22, 2026: Full Application | September 28, 2026: End of Application Verification Period
Funding Amounts: Up to $1,200,000 total costs per award over 4 years; approximately 3 awards; total program funding $3.6M.
Summary: Supports early-career independent investigators to join the Neurofibromatosis Research Academy and conduct innovative research in neurofibromatosis under intensive mentorship.
Key Information: Clinical trials are not allowed; Scholar must be ≤10 years from terminal degree; Career Guide required.
Description
This opportunity supports early-career independent investigators (Scholars) to join the Neurofibromatosis Research Academy and conduct research projects in neurofibromatosis (NF), including basic, translational, or clinical research (excluding clinical trials). The Scholar Award aims to foster the next generation of NF researchers through a collaborative, mentored environment, providing both research funding and structured career development. Projects must address at least one of the FY26 Neurofibromatosis Research Program (NFRP) Areas of Emphasis and align with the program’s mission to improve understanding, diagnosis, and treatment of NF and schwannomatosis.
